Drug utilization evaluation of nonprescription H2-receptor antagonists and alginate-containing preparations for dyspepsia

British Journal of Clinical Pharmacology

Volumn 49, Issue 4, 2000, Pages 363-368

  Krska, Janet ^b   John, David Neale ^a   Hansford, Denise ^b   Kennedy, Emily J ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b ROBERT GORDON UNIVERSITY   (United Kingdom)

Author keywords

Alginates; Drug utilization evaluation; H2 receptor antagonists; Nonprescription products

Indexed keywords

ACETYLSALICYLIC ACID; ALGINIC ACID; ANTACID AGENT; BRONCHODILATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; GASTROINTESTINAL AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; IRON; MISOPROSTOL; NITRATE; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM CHANNEL BLOCKING AGENT; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CONSTIPATION; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG USE; DYSPEPSIA; FEMALE; FLATULENCE; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PATIENT SATISFACTION; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SELF CARE; SIDE EFFECT; SYMPTOMATOLOGY; UNITED KINGDOM; XEROSTOMIA;

ADULT; ALGINATES; COMMUNITY PHARMACY SERVICES; COMORBIDITY; DATA COLLECTION; DRUG UTILIZATION; DRUGS, NON-PRESCRIPTION; DYSPEPSIA; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SCOTLAND; WALES;

EID: 0034128238     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2000.00160.x     Document Type: Article

References (26)

1. 1 Feldman M. Comparison of the effects of over-the-counter famotidine and calcium carbonate antacid on postprandial gastric acid: a randomised controlled trial. JAMA 1996; 25: 1228-1231.
2. 2 receptor antagonists (ranitidine, famotidine) on intragastric acidity. Alim Pharmacol Ther 1998; 12: 337-342.
3. 3 Mann SG, Cottrell J, Murakami A, Stauffer L, Rao AN. Prevention of heartburn relapse by low-dose famotidine: a test meal model for duration of symptom control. Alim Pharmacol Ther 1997; 11: 121-127.
4. 4 Galmiche JP, Shi G, Simon B, Casset-Semanas F, Slama A. On-demand treatment of gastro-oesophageal reflux symptoms: a comparison of ranitidine 75mg with cimetidine 200mg or placebo. Alim Pharmacol Ther 1998; 12: 909-917.
5. 5 Grimley CE, Cottrell J, Mann SG, Stauffer L, Nwokolo CU. Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo. Alim Pharmacol Ther 1997; 11: 881-885.
6. 6 Mills JG, Koch KM, Webster C, Sirgo MA, Fitzgerald K, Wood JR. The safety of ranitidine in over a decade of use. Alim Pharmacol Ther 1997; 11: 129-137.
7. 7 Annual Report Proprietary Association of Great Britain, London 1995.
8. 8 Annual Report Proprietary Association of Great Britain, London 1997.
9. 9 Baines DL, Whynes DK. Over-the-counter drugs and prescribing in general practice. Br J Gen Pract 1997; 47: 221-224.
10. 2-receptor antagonists. J Am Pharm Assoc 1997; 37: 552-556.
11. 2-antagonists. J Soc Admin Pharm 1996; 13: 150-158.
12. 2-antagonists. Br J Gen Pract 1997; 47: 99-102.
13. 13 Sivho S, Hemminki E. Self-medication of dyspepsia: how appropriate it is? Scand J Gastroenterology 1997; 32: 855-861.
14. 14 Edres MAG, Scully C, Gelbier M. Use of proprietary agents to relieve recurrent aphthous stomatitis. Br Dent J 1997; 182: 144-146.
15. 15 Evans SW, John DN, Bloor MJ, Luscombe DK. Use of non-prescription advice offered to the public by community pharmacists. Int J Pharm Pract 1997; 5: 16-25.
16. 16 Cantrill JA, Vaezi L, Nicolson M, Noyce PR. A study to explore the feasibility of using a health diary to monitor therapeutic outcomes from over-the-counter medicines. J Soc Admin Pharm 1995; 12: 190-197.
17. 17 Grewar J, MacDonald TM. Hay fever symptoms and over-the-counter remedies: a community pharmacy study. Int J Pharm Pract 1998; 6: 22-29.
18. 18 Grewar J, Matthews J, McMahon AD, MacDonald TM. Capturing data on the use of over-the-counter medicines in community pharmacy: a methodological study. Pharm J 1995; 255: R30.
19. 19 Hansford D, John DN, Krska J, Kennedy EJ. Regional differences in advice on dyspepsia medicines from community pharmacies. Pharm J 1999; 263: R12.
20. 20 Bond CM. Guidelines for dyspepsia treatment. Pharm J 1994; 252: 228-289.
21. 21 Kennedy E, Krska J, John D, Hansford D. Effect of incentives on recruitment and response rate in a community-based pharmacy practice study. Int J Pharm Pract 1999; 7: 80-85.
22. 22 Taylor J. Reasons consumers do not ask for advice on non-prescription medicines in pharmacies. Int J Pharm Pract 1994; 2: 209-214.
23. 23 Krska J, Kennedy EJ. Expectations and experiences of customers purchasing over-the-counter medicines in pharmacies in the north of Scotland. Pharm J 1996; 256: 354-356.
24. 2 antagonists. Pharm J 1996; 256: 593-596.
25. 25 Quick J, Blenkinsopp A. A community pharmacy study to compare the control of hay fever symptoms by astemizole 10mg and terfenadine 120mg. Pharm J 1991; 246: 272-275.
26. 26 MacIntyre S, Pritchard C. Comparison between the self-assessed and observer-assessed presence and severity of colds. Soc Sci Med 1989; 29: 1243-1248.